<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04364945</url>
  </required_header>
  <id_info>
    <org_study_id>H2003-234-1115</org_study_id>
    <nct_id>NCT04364945</nct_id>
  </id_info>
  <brief_title>Association Between Anesthetic Drugs for General Anesthesia and Postoperative Intelligence/Behavioral Assessment Results in Children</brief_title>
  <official_title>Association Between Anesthetic Drugs for General Anesthesia and Postoperative Intelligence/Behavioral Assessment Results in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, we compared the results of the intelligence and behavioral test performed
      after surgery between the group using sevoflurane and the group receiving dexmedetomidine and
      remifentanil, in Korean children under 2 years of age who underwent surgery under general
      anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 17, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2028</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2028</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wechsler Preschool and Primary Scale of Intelligence-IV at age of 5</measure>
    <time_frame>When the patient's age is 5 years after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Leiter International Performance Scale at age of 2</measure>
    <time_frame>When the patient's age is 2 years old after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wechsler Preschool and Primary Scale of Intelligence-IV at age of 7</measure>
    <time_frame>When the patient's age is 7 years old after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Child Behavior Checklist results</measure>
    <time_frame>When the patient's age is 2, 5 and 7 years old after surgery</time_frame>
    <description>Child Behavior Checklist results at age of 2, 5, 7</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Anesthesia and Neurotoxicity</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>General anesthesia is maintained using sevoflurane only. Sevoflurane concentration is adjusted to maintain bispectral index value between 40 and 60.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine-remifentanil(DEX-R) group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>General anesthesia is maintained using sevoflurane, dexmedetomidine (1 mcg/kg/hr) and remifentanil (0.1-0.2 mcg/kg/min). Sevoflurane concentration is adjusted to maintain bispectral index value between 40 and 60.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexmedetomidine</intervention_name>
    <description>administration of dexmedetomidine 1 mcg/kg/hr</description>
    <arm_group_label>Dexmedetomidine-remifentanil(DEX-R) group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>remifentanil</intervention_name>
    <description>administration of remifentanil 0.1-0.2 mcg/kg/min</description>
    <arm_group_label>Dexmedetomidine-remifentanil(DEX-R) group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Anesthesia is maintained using sevoflurane.</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Dexmedetomidine-remifentanil(DEX-R) group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children under 2 years of age who underwent general anesthesia for elective surgeries
             of urology, surgery, plastic surgery, orthopedics, and otolaryngology

          -  American Society of Anesthesiology Physical Status I, II

        Exclusion Criteria:

          -  Allergies to narcotic analgesics

          -  With massive bleeding or shock

          -  Heart, lung, kidney or liver disease

          -  Central / peripheral nervous system disease and disorder

          -  Any physical deformity and disorder, genetic disease, chromosomal disease

          -  Previous history of general anesthesia or sedation

          -  Additional exposure to general anesthetics or sedative drugs during follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>23 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ji-Hyun Lee, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ji-Hyun Lee, MD, PhD</last_name>
    <phone>01076658848</phone>
    <email>muslab@hanmail.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Other</state>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang-Hwan Ji, M.D., M.S.</last_name>
      <phone>+82-2-2072-3661</phone>
      <email>taepoongshin@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>April 24, 2020</study_first_submitted>
  <study_first_submitted_qc>April 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2020</study_first_posted>
  <last_update_submitted>July 22, 2020</last_update_submitted>
  <last_update_submitted_qc>July 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Ji-Hyun Lee</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neurotoxicity Syndromes</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

